Eric is co-chair of Phillips Lytle’s Life Sciences and Health Effects Team and a member of the firm’s Psychedelics and Mental Health Therapeutics Team. He has represented some of the largest international pharmaceutical companies in various life science matters across the U.S. He has defended cases centered on cutting-edge scientific…
View more